1631.9000 -2.30 (-0.14%)
NSE Jan 23, 2026 15:31 PM
Volume: 1.7M
 

1631.90
-0.14%
Motilal Oswal
Sun Pharma (SUNP) delivered in-line revenue/EBITDA in 2QFY26. Earnings came in below our estimates largely due to lower other income.
Sun Pharmaceutical I.. has an average target of 1921.38 from 8 brokers.
More from Sun Pharmaceutical Industries Ltd.
Recommended